nach oben

Current HIV/AIDS Reports

Erschienen in:

22.02.2022 | COVID-19 | The Global Epidemic (SH Vermund, Section Editor) Zur Zeit gratis

Intersecting Pandemics of HIV and SARS-CoV-2: Commentary on the Special Issue

verfasst von: Sten H. Vermund

Erschienen in: Current HIV/AIDS Reports | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

This editorial introduces this special Global Health Section on the interface of the HIV/AIDS and COVID-19 pandemics.

Recent Findings

Authors of articles in this special issue take on a variety of topics that capture how the acute COVID-19 pandemic affected global efforts towards HIV control, and how co-infection, stigma, and social determinants of disease have affected populations on multiple continents.

Summary

Two historic pandemics -- HIV/AIDS and COVID-19 -- have affected the world in our lifetimes at a level reminiscent of the 1918-1919 H1N1 influenza pandemic. We have much to learn from both experiences to optimize pandemic disease control, prevention, and management.

Gallo RC, Montagnier L. The discovery of HIV as the cause of AIDS. N Engl J Med. 2003;349(24):2283–5. https://doi.org/10.1056/NEJMp038194.CrossRefPubMed

Health Resources & Services Administration. About the Ryan White HIV/AIDS Program/Who was Ryan White? October 2016. https://hab.hrsa.gov/about-ryan-white-hivaids-program/who-was-ryan-white, accessed December 28, 2021

De Cock KM, Jaffe HW, Curran JW. Reflections on 40 years of AIDS. Emerg Infect Dis. 2021;27(6):1553–60. https://doi.org/10.3201/eid2706.210284.CrossRefPubMedPubMedCentral

Saag MS, Gandhi RT, Hoy JF, et al. Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2020 recommendations of the International Antiviral Society-USA Panel. JAMA. 2020;324(16):1651–69. https://doi.org/10.1001/jama.2020.17025.CrossRefPubMed

Shapiro SZ. Lessons for general vaccinology research from attempts to develop an HIV vaccine. Vaccine. 2019;37(26):3400–8. https://doi.org/10.1016/j.vaccine.2019.04.005.CrossRefPubMed

Hemelaar J, Elangovan R, Yun J, et al. Global and regional epidemiology of HIV-1 recombinants in 1990–2015: a systematic review and global survey. Lancet HIV. 2020;7(11):e772–81. https://doi.org/10.1016/S2352-3018(20)30252-6.CrossRefPubMed

Armoon B, Higgs P, Fleury MJ, et al. Socio-demographic, clinical and service use determinants associated with HIV related stigma among people living with HIV/AIDS: a systematic review and meta- analysis. BMC Health Serv Res. 2021;21(1):1004. https://doi.org/10.1186/s12913-021-06980-6.CrossRefPubMedPubMedCentral

Beyrer C, Baral SD, Collins C, et al. The global response to HIV in men who have sex with men. Lancet. 2016;388(10040):198–206. https://doi.org/10.1016/S0140-6736(16)30781-4.CrossRefPubMed

Song Z, Xu Y, Bao L, et al. From SARS to MERS, thrusting coronaviruses into the spotlight. Viruses. 2019;11(1):59. https://doi.org/10.3390/v11010059.CrossRefPubMedCentral

10.

Fung TS, Liu DX. Human coronavirus: host-pathogen interaction. Annu Rev Microbiol. 2019;8(73):529–57. https://doi.org/10.1146/annurev-micro-020518-115759.CrossRef

11.

Vergara-Alert J, Vidal E, Bensaid A, Segalés J. Searching for animal models and potential target species for emerging pathogens: experience gained from Middle East respiratory syndrome (MERS) coronavirus. One Health. 2017;3(3):34–40. https://doi.org/10.1016/j.onehlt.2017.03.001.CrossRefPubMedPubMedCentral

12.

Khattab NM, Vermund SH, Hu Y. How coronavirus disease 2019 entered Africa and the Middle East: a case study from Egypt. Trans R Soc Trop Med Hyg. 2020;114(10):715–7. https://doi.org/10.1093/trstmh/traa065.CrossRefPubMedPubMedCentral

13.

Lucas C, Vogels CBF, Yildirim I, et al. Impact of circulating SARS-CoV-2 variants on mRNA vaccine-induced immunity. Nature. 2021;600(7889):523–9. https://doi.org/10.1038/s41586-021-04085-y.CrossRefPubMed

14.

Cho H, Li W, Cannon J, Lopez R, Song CC. Testing three explanations for stigmatization of people of Asian descent during COVID-19: maladaptive coping, biased media use, or racial prejudice? Ethn Health. 2021;26(1):94–109. https://doi.org/10.1080/13557858.2020.1830035.CrossRefPubMed

15.

The Associated Press. Texas Lt. Gov. Dan Patrick’s COVID claim denounced as racist: Texas’ lieutenant governor is blaming unvaccinated Black people for rising COVID-19 hospitalization and death rates. Associated Press/US News and World Report, 2021, https://www.usnews.com/news/best-states/texas/articles/2021-08-20/dan-patrick-blames-unvaccinated-black-people-for-covid-surge

16.

Adrianna Rodriguez. Texas’ lieutenant governor suggests grandparents are willing to die for US economy. USA TODAY, 2020, https://www.usatoday.com/story/news/nation/2020/03/24/covid-19-texas-official-suggests-elderly-willing-die-economy/2905990001/

17.

D’cruz M, Banerjee D. ‘An invisible human rights crisis’: the marginalization of older adults during the COVID-19 pandemic - an advocacy review. Psychiatry Res. 2020;292:113369. https://doi.org/10.1016/j.psychres.2020.113369.CrossRefPubMedPubMedCentral

18.

Levy BR, Slade MD, Chang ES, Kannoth S, Wang SY. Ageism amplifies cost and prevalence of health conditions. Gerontologist. 2020;60(1):174–81. https://doi.org/10.1093/geront/gny131.CrossRefPubMed

19.

Abaluck J, Chevalier JA, Christakis NA, et al. The case for universal cloth mask adoption and policies to increase the supply of medical masks for health workers. Covid Economics (CEPR Press) 2020; Issue 5 (16 April 2020): 147–159 (https://cepr.org/sites/default/files/news/CovidEconomics5.pdf). Pre-print: Abaluck J, Chevalier JA, Christakis NA, et al. The case for universal cloth mask adoption and policies to increase supply of medical masks for health workers (April 1, 2020). Available at SSRN: https://ssrn.com/abstract=3567438 or https://doi.org/10.2139/ssrn.3567438.

20.

Haberer JE, van der Straten A, Safren SA, et al. Individual health behaviours to combat the COVID-19 pandemic: lessons from HIV socio-behavioural science. J Int AIDS Soc. 2021;24(8):e25771. https://doi.org/10.1002/jia2.25771.CrossRefPubMedPubMedCentral

21.

• James EK, Bokemper SE, Gerber AS, Omer SB, Huber GA. Persuasive messaging to increase COVID-19 vaccine uptake intentions. Vaccine. 2021;39(49):7158–65. https://doi.org/10.1016/j.vaccine.2021.10.039. One might anticipate similar challenges in public communication when an HIV vaccine is finally available for global distribution.CrossRefPubMedPubMedCentral

22.

• Solís Arce JS, Warren SS, Meriggi NF, et al. COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries. Nat Med. 2021;27(8):1385–94. https://doi.org/10.1038/s41591-021-01454-y. Residents of low- and middle-income nations may also be under the sway of anti-vaccine forces. Understanding the diversity of community sentiments is vital for all vaccine-preventable diseases.CrossRefPubMedPubMedCentral

23.

• Loomba S, de Figueiredo A, Piatek SJ, de Graaf K, Larson HJ. Measuring the impact of COVID-19 vaccine misinformation on vaccination intent in the UK and USA. Nat Hum Behav. 2021;5(3):337–48. https://doi.org/10.1038/s41562-021-01056-1. High income nations such as the UK and the US have had suboptimal vaccine coverage, despite no shortages of vaccine or distribution points. We can expect even greater challenges in less well resourced areas.CrossRefPubMed

24.

Schoch-Spana M, Brunson EK, Long R, et al. The public’s role in COVID-19 vaccination: human-centered recommendations to enhance pandemic vaccine awareness, access, and acceptance in the United States. Vaccine. 2021;39(40):6004–12. https://doi.org/10.1016/j.vaccine.2020.10.059.CrossRefPubMed

25.

Immunology of chronic HIV and acute SARS-CoV-2 co-infection: theoretical and experimental findings. Akiko Iwasaki (Yale School of Medicine)

26.

Clinical findings among HIV and SARS-CoV-2 co-infected persons. Jordi Casabona (CEESCAT, Barcelona)

27.

Maternal and newborn outcomes of COVID-19 and pregnancy: parallels and contrasts with HIV. Dan Li (Yale School of Public Health)

28.

Disruptions of HIV and tuberculosis services in a COVID-19 pandemic lockdown: the South African experience. Quarraisha Abdool Karim (CAPRISA, Durban)

29.

Socioeconomic burdens of concurrent acute COVID-19 and chronic HIV disease in vulnerable LMIC populations. Lyle McKinnon (U. of Manitoba)

30.

Psychosocial issues in COVID-19 among PLHIV. Seth Kalichman (U. of Connecticut)

31.

Social determinants of disease: contrasting HIV and COVID-19 experiences. Paula Frew (UNLV School of Public Health and UNLV Population Health & Health Equity Initiative)

32.

Integration of HIV and COVID-19 services in Africa: how did PEPFAR pivot? George Siberry (USAID) with African authors

33.

HIV and COVID-19 in Latin America. Patricia Garcia (UPCH, Lima)

34.

COVID-19 presentation among HIV-infected persons in China. Yifei Hu (CCMU, Beijing)

35.

Challenges in Asia and its special populations. Kamarulzaman

36.

Mathematical modeling of COVID-19: lessons from HIV forecasting. Gregg Gonsalves (Yale School of Public Health)

37.

Vaccines for COVID-19: How has our experience with HIV research informed SARS-CoV-2 work? Kayvon Modjarrad (Emerging Infectious Diseases Branch, Walter Reed Army Institute of Research)

38.

Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395(10224):565–74. https://doi.org/10.1016/S0140-6736(20)30251-8.CrossRefPubMedPubMedCentral

39.

Fauci A. Victories against AIDS have lessons for COVID-19. Nature. 2021;600(7887):9. https://doi.org/10.1038/d41586-021-03569-1.CrossRefPubMed

Titel: Intersecting Pandemics of HIV and SARS-CoV-2: Commentary on the Special Issue
verfasst von: Sten H. Vermund
Publikationsdatum: 22.02.2022
Verlag: Springer US
Schlagwort: COVID-19
Erschienen in: Current HIV/AIDS Reports / Ausgabe 1/2022
Print ISSN: 1548-3568
Elektronische ISSN: 1548-3576
DOI: https://doi.org/10.1007/s11904-022-00599-w

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Purpose of Review

Recent Findings

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2022

Socioeconomic Burdens of the COVID-19 Pandemic on LMIC Populations with Increased HIV Vulnerabilities

PEPFAR’s Role in Protecting and Leveraging HIV Services in the COVID-19 Response in Africa

Central Nervous System Impact of Perinatally Acquired HIV in Adolescents and Adults: an Update

HIV and COVID-19 in Latin America and the Caribbean

HIV and SARS-CoV-2 Co-infection: Epidemiological, Clinical Features, and Future Implications for Clinical Care and Public Health for People Living with HIV (PLWH) and HIV Most-at-Risk Groups

Social Determinants of Disease: HIV and COVID-19 Experiences